ERBB3 and breast cancer: Furthermore, through the NRG1-HER3 signaling axis, NRG1 contributes to malignant tumor development in certain cancer types, including gastric, pancreatic, and breast cancer, and its overexpression is closely associated with poor prognosis7,8.